Zhangzhang Lan

659 total citations
16 papers, 304 citations indexed

About

Zhangzhang Lan is a scholar working on Molecular Biology, Genetics and Cancer Research. According to data from OpenAlex, Zhangzhang Lan has authored 16 papers receiving a total of 304 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 5 papers in Genetics and 5 papers in Cancer Research. Recurrent topics in Zhangzhang Lan's work include RNA modifications and cancer (3 papers), Cancer-related molecular mechanisms research (3 papers) and Genomics and Rare Diseases (2 papers). Zhangzhang Lan is often cited by papers focused on RNA modifications and cancer (3 papers), Cancer-related molecular mechanisms research (3 papers) and Genomics and Rare Diseases (2 papers). Zhangzhang Lan collaborates with scholars based in China and Hong Kong. Zhangzhang Lan's co-authors include Xiaoming Wei, Ning Qu, Qian Zhu, Jinming Wang, Guanghui Yang, Xin Yi, Yuxing Chu, Yi Yang, Hui Jiang and Zhen Ruan and has published in prestigious journals such as Bioinformatics, PLoS ONE and International Journal of Molecular Sciences.

In The Last Decade

Zhangzhang Lan

15 papers receiving 299 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Zhangzhang Lan China	8	202	103	35	34	33	16	304
Dina Marek‐Yagel Israel	12	358 1.8×	78 0.8×	59 1.7×	34 1.0×	16 0.5×	26	507
Yu Ding China	12	219 1.1×	170 1.7×	20 0.6×	24 0.7×	35 1.1×	38	359
Monica Piccini Italy	8	240 1.2×	58 0.6×	67 1.9×	45 1.3×	63 1.9×	8	378
Stacy Roberts United States	8	241 1.2×	85 0.8×	26 0.7×	24 0.7×	37 1.1×	10	414
Britta George Germany	11	277 1.4×	148 1.4×	23 0.7×	16 0.5×	14 0.4×	20	603
Fumio Takada Japan	12	406 2.0×	151 1.5×	105 3.0×	26 0.8×	17 0.5×	33	624
Chin-To Fong United States	9	198 1.0×	95 0.9×	9 0.3×	28 0.8×	14 0.4×	9	450
Guoying Chang China	10	157 0.8×	117 1.1×	17 0.5×	11 0.3×	27 0.8×	41	258
Sandra Corbani Lebanon	10	225 1.1×	163 1.6×	10 0.3×	15 0.4×	29 0.9×	23	387
Renan Paulo Martin Brazil	12	172 0.9×	66 0.6×	25 0.7×	23 0.7×	15 0.5×	39	314

Countries citing papers authored by Zhangzhang Lan

Since Specialization

Citations

This map shows the geographic impact of Zhangzhang Lan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhangzhang Lan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhangzhang Lan more than expected).

Fields of papers citing papers by Zhangzhang Lan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zhangzhang Lan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhangzhang Lan. The network helps show where Zhangzhang Lan may publish in the future.

Co-authorship network of co-authors of Zhangzhang Lan

This figure shows the co-authorship network connecting the top 25 collaborators of Zhangzhang Lan. A scholar is included among the top collaborators of Zhangzhang Lan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zhangzhang Lan. Zhangzhang Lan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

Lan, Zhangzhang, et al.. (2025). NID2 Affects Prognosis of Glioma via Activating the Akt Signaling Pathway. International Journal of Molecular Sciences. 26(8). 3859–3859.

Lan, Zhangzhang, et al.. (2024). CircPRDM5 inhibits the proliferation, migration, invasion, and glucose metabolism of gastric cancer cells by reducing GCNT4 expression in a miR‐485‐3p‐dependent manner. The Kaohsiung Journal of Medical Sciences. 40(3). 231–243. 4 indexed citations

Niu, Li, Boyu Wu, Lei Deng, et al.. (2023). Copy number variants landscape of multiple cancers and clinical applications based on NGS gene panel. Annals of Medicine. 55(2). 2280708–2280708. 3 indexed citations

Lan, Zhangzhang, et al.. (2022). Comprehensive bioinformatics analysis of functional molecules in colorectal cancer. Journal of Gastrointestinal Oncology. 13(1). 231–245. 12 indexed citations

Luan, Hemi, Hua Li, Zi Wang, et al.. (2021). Serum metabolomic and lipidomic profiling identifies diagnostic biomarkers for seropositive and seronegative rheumatoid arthritis patients. Journal of Translational Medicine. 19(1). 500–500. 53 indexed citations

Wang, Li, et al.. (2021). A Chinese family with Noonan syndrome caused by a heterozygous variant in LZTR1: a case report and literature review. BMC Endocrine Disorders. 21(1). 2–2. 5 indexed citations

Luan, Hemi, et al.. (2020). CPVA: a web-based metabolomic tool for chromatographic peak visualization and annotation. Bioinformatics. 36(12). 3913–3915. 4 indexed citations

Liu, Ying, et al.. (2020). Analysis of a Chinese Pedigree With Familial Chylomicronemia Syndrome Reveals Two Novel LPL Mutations by Whole-Exome Sequencing. Frontiers in Genetics. 11. 741–741. 1 indexed citations

Zhang, Tongda, et al.. (2017). Syntool: A Novel Region-Based Intolerance Score to Single Nucleotide Substitution for Synonymous Mutations Predictions Based on 123,136 Individuals. BioMed Research International. 2017. 1–5. 8 indexed citations

10.

Zhang, Yonghong, Jing Zhou, Zhangzhang Lan, et al.. (2016). Clinical, biochemical and molecular analysis of two infants with familial chylomicronemia syndrome. Lipids in Health and Disease. 15(1). 88–88. 6 indexed citations

11.

Dai, Yi, Xiaoming Wei, Yanhuan Zhao, et al.. (2015). A comprehensive genetic diagnosis of Chinese muscular dystrophy and congenital myopathy patients by targeted next-generation sequencing. Neuromuscular Disorders. 25(8). 617–624. 26 indexed citations

12.

Wei, Xiaoming, Rui Chen, Hanlin Zhou, et al.. (2013). A novel mutation of the SLC25A13 gene in a Chinese patient with citrin deficiency detected by target next-generation sequencing. Gene. 533(2). 547–553. 11 indexed citations

13.

Wang, Hui, Yan Sun, Weiqing Wu, et al.. (2013). A novel missense mutation of FGFR3 in a Chinese female and her fetus with Hypochondroplasia by next-generation sequencing. Clinica Chimica Acta. 423. 62–65. 7 indexed citations

14.

Xie, Shuqi, Zhangzhang Lan, Ning Qu, et al.. (2012). Detection of truncated dystrophin lacking the C-terminal domain in a Chinese pedigree by next-generation sequencing. Gene. 499(1). 139–142. 18 indexed citations

15.

Sun, Yan, Lixia Wang, Xiaoming Wei, et al.. (2012). Analysis of a Chinese pedigree with Zellweger syndrome reveals a novel PEX1 mutation by next-generation sequencing. Clinica Chimica Acta. 417. 57–61. 12 indexed citations

16.

Wei, Xiaoming, Xiang-Chun Ju, Xin Yi, et al.. (2011). Identification of Sequence Variants in Genetic Disease-Causing Genes Using Targeted Next-Generation Sequencing. PLoS ONE. 6(12). e29500–e29500. 134 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact